Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: What is the impact of JAK2 inhibitor therapy?

Raoul Tibes, Ruben A. Mesa

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: What is the impact of JAK2 inhibitor therapy?'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience